ResMed (RMD ASX) Offloads Aged Care Software Business for $707 Million Amid AI Concerns
Australian Financial Review
ENRICHED
Details
- Date Published
- 8 July 2026
- Priority Score
- 1
- Australian
- Yes
- Created
- 8 July 2026, 08:01 pm
Description
The medical device maker has sold the MatrixCare business for less than it bought it for eight years ago, with analysts pointing to potential AI disruption.
Summary
This article examines the sale of ResMed's MatrixCare software business, highlighting how rapid advancements in AI capabilities are disrupting traditional healthcare software markets and depressing asset valuations. The shift suggests that legacy management systems are increasingly viewed as vulnerable to obsolescence compared to emerging AI-driven healthcare platforms. While primarily focused on market disruption and corporate strategy, it underscores the economic pressure on incumbents to adapt to frontier AI tools or risk total displacement. The development is relevant to Australian listed companies navigating the intersection of biotech, aged care, and AI-driven automation.
Body
CompaniesHealthcare & FitnessHealthcarePrint articleMichael SmithHealth editorUpdated Jul 8, 2026 – 5.06pm, first published at 1.32pmResmed has sold an underperforming software business focused on residential aged care to a US private equity firm for $707 million, about a third less than what it paid for the asset eight years ago, in a move analysts say reflects the risk that artificial intelligence renders it obsolete.Resmed said the sale of MatrixCare, which provides software used to manage care, nutrition and payroll in nursing, senior living and retirement facilities, to Frazier Healthcare Partners, was part of a strategy to focus on its core sleep health business.Loading...SaveLog in or Subscribe to save articleShareCopy linkCopiedEmailLinkedInTwitterFacebookCopy linkCopiedShare via...Gift this articleSubscribe to gift this articleGift 5 articles to anyone you choose each month when you subscribe.Subscribe nowAlready a subscriber? LoginLicense articleRead MoreHealthcareResMedCSL LimitedCochlearAnthropicHealthAIBiotechSoftwareFuture technologySharesASX LimitedAged careActivist shareholdersFetching latest articles